Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
Total Equity
Prestige Consumer Healthcare Inc
Total Equity Peer Comparison
Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors
Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
Total Equity
$1.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
11%
|
|
Johnson & Johnson
NYSE:JNJ
|
Total Equity
$70B
|
CAGR 3-Years
2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-1%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Equity
$16.5B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
2%
|
CAGR 10-Years
1%
|
|
Pfizer Inc
NYSE:PFE
|
Total Equity
$89B
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
1%
|
|
Merck & Co Inc
NYSE:MRK
|
Total Equity
$40.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-2%
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Equity
$12.8B
|
CAGR 3-Years
23%
|
CAGR 5-Years
39%
|
CAGR 10-Years
-4%
|
See Also
What is Prestige Consumer Healthcare Inc's Total Equity?
Total Equity
1.6B
USD
Based on the financial report for Dec 31, 2023, Prestige Consumer Healthcare Inc's Total Equity amounts to 1.6B USD.
What is Prestige Consumer Healthcare Inc's Total Equity growth rate?
Total Equity CAGR 10Y
11%
Over the last year, the Total Equity growth was -5%. The average annual Total Equity growth rates for Prestige Consumer Healthcare Inc have been 7% over the past three years , 5% over the past five years , and 11% over the past ten years .